Drug markets have been targeted for increasingly tough enforcement yet retail prices for cocaine and heroin fell by 70-80%. No research has explained adequately why prices have fallen. This paper explores the possibility that part of the explanation may lie in the failure of drug dealers to respond to risks the way the simplest rational actor models might predict. 
• The economic return from dealing is the monetary or accounting profit minus the dollar value of non-monetary risks and costs incurred.
• Conventional costs of production are too small to explain or drive prices.
This can be summarized in an equation:
Economic return on dealing = Revenue from selling drugs -Cost of obtaining the drugs Conventional business costs -Non-monetary costs.
(
If the return on dealing is governed by the opportunity cost of dealing, then it should be relatively insensitive to changes in enforcement. Since conventional business costs are negligible, this implies that the mark-up (i.e., the difference between sales revenue and the cost of obtaining drugs) is driven primarily by the non-monetary costs.
The sum of the mark-ups from one layer of the distribution chain to the next is what determines the retail price. The risks of enforcement and violence are the dominant nonmonetary costs. So, mathematically, one would expect increasing enforcement to drive up non-monetary costs and, hence, prices.
incarcerated; many sellers are also users.
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Less formally, the risks and prices framework views enforcement as a sort of tax that drives up the cost of distributing drugs. Since drug dealers are essentially business people, one would expect them to pass those higher costs along to consumers in the form of higher prices. Both before and after any change in the amount of enforcement, drug dealers are viewed as having made a rational choice. They considered the risks. They considered the rewards (primarily monetary). And they chose the bundle of risks and rewards associated with dealing over whatever the alternative was. Raising the risks makes the bundle look less attractive, so to preserve an equilibrium in which the marginal individual is indifferent between choosing the risky bundle and the less risky default alternative, rewards must rise when risks do.
Conventional Explanations for the Conundrum
The previous section described a paradox. The bulk of this paper examines the possibility that various cognitive failures or failures of judgment might help explain that paradox. Before proceeding it is important to make two observations. First, it is unlikely that there is just one explanation for why cocaine and heroin prices fell when enforcement increased. That is why we say failures in judgment may help explain the paradox, not explain it entirely. Second, some of the other explanations do not involve judgmental failure. We review them next. They do not necessarily make this paper moot, however, because these explanations are not typically viewed as being sufficient in themselves to explain all of what happened with prices, even if they are an important part of the overall explanation.
Price Declines Were the Result of Demand Shifts
A common explanation for falling prices is an upward sloping supply curve (the usual case) and declining demand. Superficially this might seem like a relevant explanation because the number of cocaine users (though not necessarily heroin users) has fallen. However, demand is dominated by heavy users, whose numbers grew in the 1980s. Everingham and Rydell (1994) estimate that the weighted sum of the number of light and heavy cocaine users, weighting by their relative propensities to consume, was stable during the 1980s, and Knoll and Zuba's (2002) update shows only very modest declines during the 1990s. Heroin use is harder to estimate but, if anything, may have been increasing (ONDCP, 1999) . So falling demand cannot explain the price declines.
Conversely, the stability in cocaine demand undermines another explanation, namely that growing demand coupled with a downward sloping supply curve is behind the cocaine price declines. Downwardly sloping supply curves are unusual but can occur when there are few scarce factors of production and there are industry-wide external economies of scale (Samuelson, 1973) , which could be the case for drug distribution.
The risks and prices model suggests that prices should be driven by the intensity of enforcement, rather than its total magnitude. That is, it is not the number of people 
Learning-by-Doing and Other Efficiency Gains
Drug prices may have fallen for the same reason computer prices did. The producers may have become more efficient at their craft (cf. Cave & Reuter, 1988; Kleiman, 1989 01/27/03 6
Tough Enforcement Might Have Perverse Effects
A more pessimistic explanation is that enforcement was not only swamped by naturally occurring innovation but that increasing enforcement stringency actually prompted that innovation. E.g., Kleiman (1989) suggests that tougher marijuana enforcement encouraged smugglers, dealers, and users to substitute into cocaine because it was easier to conceal, and some have made similar suggestions concerning the invention of crack (Friedman, 1989) .
Likewise the increasing stringency of enforcement was accompanied by a change in who was using, who was selling, and where the selling occurred. To caricature, in 1980 cocaine was a rich person's drug purchased through social networks from people who moved in the same cultural and economic circles as the users. In 1990, it was a ghetto drug. Even though most users were not poor, most of the smaller number of heavy users who accounted for the majority of the consumption were. And most selling was done by "professional" sellers who interacted with their customers primarily to transact drugs. Often these sellers were young and had limited opportunities in legitimate labor markets. It is not clear which if any of these trends caused the others, but perhaps increasing enforcement discouraged sellers for whom sanctions were particularly costly.
The customary challenge to arguments for perverse effects is, in effect, that if suppliers were able to cut costs and increase revenue under prohibition and stiffer enforcement, why wouldn't they have done so under prohibition with standard enforcement, to improve profits and beat their competitors? One can generate some plausible answers (cf. Rasmussen and Benson, 1994) . E.g., in an atomized market with poor information flows, it can be optimal for every individual to do things in ways that other market participants recognize and understand, so change may not occur until an exogenous force such as enforcement makes the status quo untenable. In general, however, these answers are compelling only for particular contexts and are not likely to explain the overall paradox of price declines.
Diminishing Marginal Effectiveness to Increased Enforcement
There are several reasons why enforcement's marginal effect on prices may diminish with increasing enforcement intensity. By themselves they can only explain why prices didn't increase very much, not why prices actually fell, but they could have played a role in conjunction with other factors.
First, there are what Reuter (1983) calls the "structural consequences of product inequality." The mere fact that drugs are illegal, and that prohibition is not rendered vacuous by a complete absence of enforcement, compels drug suppliers to operate in inefficient ways. For example, they have trouble establishing fixed business locations, advertising, and entering into enforceable contracts.
Second, the consequences of subsequent convictions may be less severe than the consequences of the first in terms of reduced labor market opportunities, social approbation from friends and family, ineligibility for governmental benefits, etc.
Likewise, extending sentences may be less cost-effective than imposing shorter sentences (Caulkins, Rydell, Schwabe, and Chiesa, 1997) .
Third, it has been hypothesized that the larger the proportion of one's peer group that has been sanctioned, the smaller is the social stigma of receiving that sanction (see Jacobse n & Hanneman, 1992; McGraw, 1985; Petersilia, 1990) , a phenomenon that might be called "stigma swamping" (following Kleiman's term "enforcement swamping," discussed above).
The Market May Not Have Been in Equilibrium in 1980
The risks and prices argument applies to the long-run equilibrium prices.
Economics in general is vague about how long one has to wait for long-run considerations to dominate. The economics of drug markets are no different in that regard. Cocaine as a mass-market phenomenon was relatively new in the US in 1980.
Perhaps prices in 1980 were "too high" in the sense of being out of equilibrium, and dealers then were reaping "supernormal" profits. If so, then the mystery is not why prices fell but rather why prices didn't fall faster, and the answer may simply be that information flows very imperfectly in illicit markets so it takes time for the equilibrium to be restored.
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These points are relevant and may have contributed to the decline in cocaine and heroin prices. But even in total, they do not present an entirely satisfactory explanation for why enforcement has been so singularly ineffective at driving up prices. So we now introduce another possible explanation, namely that drug enforcement may not deter drug dealers in quite the way the risks and prices paradigm would suggest.
The Limits of Deterrence
The risks and prices paradigm views drug enforcement as working through deterrence. A given intensity of enforcement deters people from selling drugs at prices that provide less than a certain monetary reward. Increasing enforcement risk reduces the range of prices at which drug dealing will be pursued, just as raising the risk of arrest for burglary restricts the number of burglaries that are sufficiently rewarding to commit.
To work, deterrence depends on the object of the enforcement threat behaving with some degree of "rationality" in the sense of consistently choosing courses of action that improve one's well-being relative to the alternatives. As Kleiman (1992) points out, agents of the state including the police do not often literally use force to achieve compliance. Even when a police officer draws a gun and orders a suspect to lie down, the officer is depending on the suspect to choose the benefits of complying with the order over the costs of not complying, namely being shot. If the suspect isn't capable of responding to incentives or making self-interested choices, deterrence will not achieve the desired end.
In essence, the question we raise here is whether rational actor models describe drug dealers' behavior well enough for deterrence to work as is implied by the risks and prices theory. (See MacCoun [1993] for a similar analysis focusing on drug use rather than selling.) We do not for a minute doubt that most if not all drug dealers are capable of responding to incentives. Certainly, we expect most would respond to the threat of a police officer's drawn gun. But the fact that someone responds to incentives is not sufficient evidence to conclude that they are maximizing expected net revenues, utility, or any other objective function. When the price of a good (or activity) goes up, individuals who are consistently maximizing an objective function will not only tend to consume less of the good, they will reduce consumption by a very specific amount as dictated by the particulars of their objective function and the price change. If they reduce consumption but by a different amount they are responding to incentives but their behavior would not necessarily be well predicted by a rational actor model.
A gap between actual behavior and the predictions of rational actor models could emerge because of "bounded rationality" (Simon, 1957) . I.e., the individual might rationally chooses not to maximize a given, narrow objective function if the information collection and processing costs are too great. Or the gap could stem from behavior that is not even rational in a bounded sense. As Boyum (1992) observes, the latter is much more plausible for drug sellers than for licit businesses because drug enterprises are essentially never driven out of business by negative accounting profits. They can operate indefinitely with negative economic profits (return), but still meet payroll if dealers are not receiving full compensation for risk.
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A central premise of this article is that for the decision to sell drugs deviations from a naïve notion of rationality are likely to be large, whether because of bounded rationality or even "less rational" behavior.. In particular, we hypothesize that they are large enough to play an important role in explaining why increasing enforcement intensity hasn't had the effect on prices that the risks and prices model would predict.
From a modeling perspective, the implication is that the return to dealing need be only weakly related to the return on alternative activities.
We have no way at present to quantify the departures from simple rational choice on dealer behavior. The goal of this paper is simply to make a case for plausibility by pointing out that the structure of the decision to sell drugs parallels structures that the literature reports lead to perverse behavior, either in controlled experiments or in naturalistic settings.
The case has an a fortiori character in the following sense. We strive to show that even modest departures from the classical model of decision-making are sufficient to break the link between drug enforcement and drug prices. To the extent that in reality the decision to sell drugs is even more spontaneous, emotional, and idiosyncratic than we describe, then the conclusion holds with even greater force.
Consistent with this a fortiori character, we consider how the decision to deal might look to someone who tries to look carefully and quantitatively at data concerning the benefits and costs of selling. This discussion is pursued in two parts. First we consider someone who has accurate and representative data concerning the probabilities and consequences of various outcomes. Then we consider reasons why these "inputs" to the decision process may be biased. We also distinguish between three stages of a dealing career: the decision to sell for the first time or first few times, the decision to escalate to regular selling, and the decision to continue selling even after being sanctioned.
The Initial Decision to Sell Drugs
To discuss how human frailties might play havoc even with a data-driven attempt to weigh carefully the benefits and costs of selling drugs, it is helpful to use specific numbers. The decision model described is by no means the most sophisticated or inclusive one could devise. We keep it simple for expositional purposes and trust the reader to see that the points made are robust with respect to such elaborations.
Most applications of the risks and prices framework have assumed the decision to deal can be modeled as if it is made on an expected value basis (e.g., Caulkins et al., 1997) . That is, the marginal dealer is perceived as someone for whom the expected value of the benefits of dealing equals the expected value of the costs, including the opportunity cost of not dealing. Reuter, MacCoun, and Murphy (1990, pp. 102-105) include an example of this approach. They estimated that someone who sells drugs regularly for a year (at retail, in Washington, DC, in the 1980s) made an average of $27,000 per year, net of the cost of buying the drugs. 5 Reuter et al. estimated that such an individual faces a seven percent chance of serious injury, a 1.4% chance of being killed, and a 22% probability of incarceration with an estimated average time served of 18 months. They hypothesize that these individuals might value a serious injury at $30,000, a 1% risk of death at $7,500, and a year in prison at the opportunity cost in terms of lost wages ($27,000 per year), and thus describe the average return to a year of regular dealing as:
$27,000 -[0.07 * $30,000 + 0.014 * $7,500 + 0.22 * 1.5 years * $27,000/year] = $5,500 per year Assuming regular dealers spend an average of 15.9 hours per week selling, this works out to $6.65 per hour worked.
Some of these reasons are psychological. With respect to probability judgment, people often fail to understand that activities with small per-transaction risks can have very large cumulative risks (Doyle, 1997) . With respect to the evaluation of outcomes, people tend to frame choices narrowly and locally rather than broadly and globally (see Kahneman & Tversky, 2000) . And it is likely that drug dealing (like other crimes) dispro portionately attracts those high in impulsivity and low in self control (Gottfredson & Hirschi, 1990) , implying short time horizons.
There are also structural factors that discourage long-term planning. Drug dealers have no employment contracts or union rules prohibiting part-time work nor minimum time commitments as in the military. Part-time selling or "moonlighting" as a drug seller is common (Reuter et al., 1990) , and the more natural unit of commitment to selling is to carry out one cycle of buying drugs from a supplier, dividing the packages into smaller units, and selling those smaller units to customers. Suppliers generally take a dim view of efforts to return merchandise; they offer no money-back guarantees. This makes it costly to abandon dealing mid-cycle, but cycles are short, typically ranging from a few hours to a few days or a week. There is no yearlong obligation.
Thus when someone is considering whether to sell drugs for the first time it is probably more realistic to describe them as deciding whether to execute one drug selling cycle, not deciding whether to commit to sell for a longer period of time, such as a year.
Consistent with this argument, Reuter et al. (1990, p.82) found that relatively few adolescents (in a sample that included quite a few drug dealers) thought they would sell drugs after they left school, even though dealing was actually more prevalent among older cohorts in their neighborhoods.
Decision trees are a useful tool for depicting choices (Raiffa, 1968) . Figures 1a and 1b use decision trees to illustrate how the "commit for a year" and "commit for a cycle" perspectives differ. In each case the choice, represented by a box, is to sell drugs or not, and in each case the result of choosing to sell drugs is uncertain, represented by the arrows emanating from the circle, with outcomes ranging from very bad ("death") to very good ("successfully selling the drugs while incurring no sanction"). The specific payoffs and probabilities differ, however. One is more likely to evade sanction while selling one cycle as opposed to one year (99.3% chance vs. only a 64.1% chance), but the 01/27/03 13 payoff for doing so is more modest ($450 vs. $27,000). The risks, valuations of outcomes, and definition of a cycle are specified in Appendix A. The arrest and conviction probabilities are derived from national data, but are quite similar to the Washington DC-based figures used above. We assume a regular dealer can complete 60 cycles per year. The relationship between the per-cycle and peryear probabilities of adverse outcomes is that implied by a "Bernoulli Process" or "coin toss" model. For example, if the probability of being killed during one cycle is p, we assume the probability of being killed while attempting to execute 60 cycles is 1 -(1 -p) 60 . We do not think the Bernoulli model is descriptively accurate, but we want to suppress issues such as discounting, diminishing returns, and skill increasing with experience in order to make the contrast between Figures 1a and 1b be a function only of the time horizon.
We suspect that more people find the "deal" option appealing in Figure 1b , which takes a per-cycle perspective, than prefer the "deal" option in Figure 1a . Agreeing to sell drugs for a year is agreeing to a one-third chance of criminal sanction and a one-in-five chance of being incarcerated. A one-in-three chance of failure is sobering. Recall the warning to freshmen in the past when university retention rates were lower. "Look left.
Look right. One of the three of you will not graduate."
On the other hand, in Figure 1b there is a better than 99% chance of getting away without any adverse consequences. One does not have to be Don Quixote to "give it a go" when the chance of suffering any adverse consequence is less than one in a hundred.
Indeed, some well-known psychological tendencies might lead individuals to choose to deal when looking at Figure 1b even if they would not do so in Figure 1a . In particular, Prospect Theory (Kahneman & Tversky, 1979) suggests that people are riskaverse with respect to gains and risk-seeking with respect to losses, with gains and losses Another component of prospect theory, however, points in the opposite direction.
There is evidence that people weight outcomes not by their probabilities but by a nonlinear function of those probabilities (Appendix B). In particular, "diminishing sensitivity" implies that the impact of a given change in probability diminishes as one moves away from either extreme of certainty (i.e., for outcomes that occur with probability zero or one). Since deciding to deal for even one cycle moves the probability of arrest, incarceration, and death from zero to a positive number and these low probabilities get amplified by the decision weighting function, this phenomenon would tend to discourage people from deciding to deal when considering the "per-cycle"
perspective. Indeed, an actor applying prospect theory's nonlinear decision weighting function would not choose to deal drugs given any of the decision trees we examine in this paper, even in cases where expected value theory predicts drug dealing.
8 Functions f(x) for which this is true include f(x) = ln(x+1), sqrt(x), 1 -exp(-x/R) for R less than about How this nonlinear decision weighting plays out in practice is complicated by the fact that in reality the "Don't Deal" option involves some risk. E.g., for a property criminal who has a baseline annual arrest risk of 0.2, the nonlinear decision weighting would tend to reduce rather than increase the weight placed on additional risk of arrest.
Still such arguments are unlikely to apply to the incremental risk of death. Very few people have a baseline death risk of more than a few percent over their relevant planning horizon. Tversky and Kahneman (1992, p. 303) argue that this nonlinear function "is not well-behaved near the endpoints, and very small probabilities can be either greatly overweighted or neglected altogether." Perhaps some people are repelled by the "per cycle"
framing, e.g. because nonlinear weighting amplifies the death risk, and they never sell, but others view the probabilities of death as essentially zero and have high baseline risks of arrest, so they proceed. Since not everyone decides to sell drugs, we only need to understand why some people might not be deterred, not why none are deterred.
At any rate, the fundamental observation is that unlike expected value calculations, prospect theory suggests that the duration of dealing contemplated (one cycle or one year) can affect whether the "Deal" or "Don't Deal" option seems more appealing. If the duration is one cycle and the tendency to be risk averse with respect to gains and risk averse with respect to losses swamps the nonlinear weighting effect, then someone who would not agree to sell for a year, might still decide to sell for a cycle.
The Decision to Continue Selling Drugs
The mechanism just described may help explain why some people decide to execute a drug selling cycle once or, by extension, a few times, even if they would not commit initially to selling drugs for an entire year. Yet the phenomenon we seek to explain is not why some people dabble with dealing but why so many become regular dealers in the face of stiff enforcement. Is there something about having sold a moderate number of times that makes people more willing to commit to selling on an ongoing basis? In short, the answer is yes.
A key insight is that most people who execute a few selling cycles incur no sanction for that activity. With the parameters in Figure 1 , fewer than four in a hundred people would experience any adverse outcome during their first month of regular selling 01/27/03 3 (five cycles at a pace of 60 cycles per year). Nine out of ten sell for three months without incident. 01/27/03 4
Figure 2b: Tree for Selling for One Cycle with Zero Point Being Selling Successfully
This reframing, or shifting of the zero point, could make dealing on an on-going basis considerably more appealing relative to the alternative because "risk seeking is prevalent when people must choose between a sure loss and a substantial probability of a larger loss" (Tversky & Kahneman, 1992 ). As Figure 2 shows, when selling successfully is the zero point, the decision to stop selling generates a guaranteed loss. If this tendency to be risk-seeking with respect to losses is strong enough, then the re-framing makes selling for a year more appealing than working for a year at another job even if selling for a year would not be preferred in Figure 1a . Indeed, that is the case with all of the simple utility functions mentioned above.
Judgmental Errors and Biases
Even if we are wrong and dealers do integrate risk and outcome information in a completely rational manner, it is highly unlikely that they could accurately assemble the relevant inputs to the choice process. The most obvious problem is lack of relevant data.
Drug policy analysts lack good estimates of the risks and rewards of drug selling, and there is little reason to believe individual citizens, through casual induction, could even 01/27/03 5 approximate the relevant parameters. Furthermore, there are reasons why prospective dealers' estimation errors might not only be large but also be systematically biased in ways that undermine the ability of enforcement to deter dealing.
Availability Heuristic
Prospective sellers might underestimate the average risk of selling because of the stru cture and complexity of the decision tree. Selling drugs involves a large number of actions, any one of which could go wrong from the dealer's perspective and lead to injury or arrest. The supplier might defraud the prospective seller. The seller might be robbed.
Any of the sellers' customers might turn out to be an informant. A sale might be observed by a police officer. People tend to ignore the full range of plausible causes of failure when assessing a course of action, which can lead to significant underestimation of the total probability of failure (Fischhoff, Slovic, & Lichtenstein, 1978; Ofir, 2000) .
Also, aspects of the arrest and incarceration process tend to dilute casual 
Optimism Bias
A second factor that will tend to promote the decision to deal is "optimism bias," the general tendency of people to have unrealistic optimism about their personal risk of experiencing negative events, even if they have an accurate sense of the risks incurred by people generally (see Weinstein, 1980; Weinstein & Klein, 1996 .) A familiar variant is that the majority of drivers consider themselves to be more skillful than the average driver (Svenson, 1981) . MacCoun (1993) suggests that drug users and drug sellers are likely to suffer from a similar bias.
Vicissitudes of the Moment
One reason someone might sell for a cycle, even if they wouldn't sell for a year, is that they have very compelling reasons for needing cash quickly. There may be moments in the chaotic and cash-constrained life of a young adult when the desire for quick cash seems particularly urgent, whether the reasons are dramatic (e.g., owing money to someone who will punish non-payment with physical assault) or pedestrian (wanting to impress a date by spending lavishly).
Intoxication
Perhaps the most obvious source of distorted judgments is that a high fraction of drug sellers are active drug users. This was true even at the height of the crack epidemic when drug selling was arguably at a historic high point; even abstainers who became sellers often later succumbed to temptation and became heavy users (Reuter et al., 1990) .
Street drugs tend to impair the same kind of frontal lobe "executive cognitive functions" that are necessary for rational deliberation and planning (Fishbein, 2000) .
Over-Generalization from Early Successes
Suppose that for whatever reason (per-cycle framing effects, intoxication, etc.)
someone sells for a few cycles. As mentioned, most likely they would not suffer any adverse consequences. Given that experience, how should such "successful" sellers view the risks of continuing to sell?
In the spirit of Bayesian statistics, one's posterior probability estimate should combine one's prior estimate with the new information obtained by having sold without incident. Statistically, limited experience should provide limited confidence, but people are notoriously insensitive to sample size and tend to give much greater weight to salient personal experiences than to more abstract base rate statistics (Kahneman & Tversky, 1974) . Perceptual deterrence studies on petty crimes like marijuana smoking and shoplifting show that offenders who do not get arrested tend to revise downward their estimates of the probability of criminal sanctions (see MacCoun, 1993 , Paternoster, 1987 . It seems plausible that similar "experiential effects" would occur for drug selling.
Moreover, several psychological and social mechanisms make selling the first time like "crossing the Rubicon." Psychologically, one has crossed a symbolic moral threshold; once you have sold drugs once, the personal shame of selling a second time is greatly diminished (MacCoun, 1993) . There is likely to be a similarly diminishing marginal effect of the public stigma associated with being a drug seller, even if one is not arrested. Indeed, the labeling theory tradition in sociology and psychology would predict that this stigma will push the offender further from mainstream opportunities and relationships and further toward criminality.
Implications for Deterring Other Types of Activities
The forgoing suggests that various cognitive factors can combine with framing to "entice and trap" people into choosing to become regular drug sellers. Note this "trap" stems from the fundamental structure of this decision, not its drug-related context.
Hence, if the trap is an important contributor to the prevalence of drug selling, it may also be relevant for other high-risk behaviors such as speeding, driving while intoxicated, using addictive drugs, engaging in unprotected risky sex, and participating in extreme sports. Conversely, insights and intuition developed in those contexts may be informative when analyzing drug policies.
The fundamental structure is the following. We observe that many people repeatedly engage in risky behaviors for which the probability of severe loss per "transaction" is modest but for which the cumulative probability of severe loss from ongoing participation is substantial. In particular, this occurs even when the cumulative risk, coupled with the magnitude of the loss, is so large that it is not easy to explain why so many people engage in the behavior so frequently.
In all these contexts, it is easy to imagine that the first time people undertake such an activity, they are only deciding to "take a chance" "just this once". They do not necessarily make a conscious decision to abandon their previous pattern of prudent behavior altogether and commit to participating in the risky activity for some number of years. That is, the decision to engage in the risky activity is done at first on a "per transaction" basis.
There are a variety of reasons why someone who would not commit to a risky activity on an on-going basis might do so for a transaction or two. We introduced one novel, structural explanation that stems from being risk-averse with respect to gains and risk -seeking with respect to losses relative to the status quo, which is the natural reference point (in the prospect theory sense of the word). There are also mathematically less interesting but probably more common reasons (intoxication, peer pressure, extreme moods or circumstances, etc.).
In all likelihood, an individual who decides to take the gamble on a half dozen or so occasions for whatever reasons will suffer no adverse consequences because the probability of loss on any one transaction, or even any six or ten transactions, is not great.
At this point various biases discussed above may take effect (e.g., the salience of the individual's own recent "success" relative to abstract statistics describing frequent failure and the tendency to move the reference point to be taking the gamble and winning as opposed to not gambling). A tendency to be risk seeking in the face of losses may then make the individual decide to persist in the activity.
The Decision to Continue Selling Drugs Even After Receiving a Sanction
The previous sections sought to explain why individuals might start selling drugs even if the objective risks of doing so are high. But most people who sell full time for a period of years will eventually get arrested. The risk per cycle is not very high, but the cumulative risk over hundreds of cycles is. When enforcement intensity increases, the number of cycles until the first arrest should go down and the consequences of arrest should go up. Even if enforcement is not very effective at preventing people from starting to sell drugs, why don't people stop selling when they get arrested? Empirically recidivism is common, and at first blush that is hard to understand in an era of severe sanctions.
We offer three classes of explanations. First, we described the choices available to the individual as selling drugs or working at another job, perhaps in the legitimate economy. However appealing working in the legitimate economy was before the individual is ar rested, that alternative is likely to be less appealing after. During the months the individual was selling successfully, he or she was probably not building human capital in ways that are rewarded by the job market. Furthermore, arrest and conviction can directly reduce labor market opportunities (Freeman, 1995) . Tougher enforcement might even reduce the returns convicted dealers can earn from legitimate work if it stigmatizes them.
Second, the average sanction following arrest for a drug law violation is quite severe, but the mode and median are not. Arrestees, particularly first time arrestees, have a relatively low probability of being incarcerated, even though if they are incarcerated, the sentence can be quite severe.
In particular, in Appendix A we estimate that only half of arrests for drug sale or manufacture lead to a conviction. 9 That implies that the modal and median sanction given arrest is nothing but the arrest itself. Of those who are convicted, only about half are sent to prison, with another quarter sentenced to jail. Furthermore, many drugsentencing statutes have enhanced sanctions for repeat offenders. Since the overall averages pool outcomes for first-time and subsequent convictions, this implies that the sanction following the first conviction is even less likely to involve incarceration. In some sense the criminal justice system currently gives drug sellers one or two relatively free bites of the apple (Caulkins & Heymann, 2001 ). There are compelling arguments for being lenient with first time offenders. Enhancing deterrence is not one of them.
Most drug sellers may initially fear the consequences of arrest. If they then experience no substantial consequence from an arrest, that arrest might lead them to revise down not up their assessment of overall enforcement risk. That is, even if they revised upward their estimate of the probability of arrest, they might revise down their estimate of the severity of the consequences of arrest. This possibility is merely a conjecture, but there is evidence that the average person over-estimates the probability of arrest and the severity of sanction (see MacCoun, 1993 for a review) and Kim et al. (1993) find that drug offenders who were given only probation upon (second) conviction had a very high propensity to recidivate. So it is at least plausible that arrest and conviction can lead the seller to see the criminal justice system as a paper tiger -until the conviction that sends the individual away for many years, at which point perceptions and deterrence are irrelevant and incapacitation dominates.
Also, depending on their experiences behind bars, memories of an incarceration experience are likely to be less aversive than either the actor's original expectations, or the actual experience as it occurred (see Frederick & Loewenstein, 1999 , for a theoretical analysis and review of relevant evidence; also see Petersilia, 1990 ). Due to both psychophysical adaptation and social coping, the early period of imprisonment is likely to be the most aversive for most inmates. But memories of the event will be strongly influenced by a recency effect.
Finally, for a variety of reasons an adverse outcome after a string of successes might not change behavior as much as a naïve behavioral model might suggest. For one, decision-making experimentation illustrates that individuals exhibit a strong status quo bias, a tendency to remain with a particular alternative even though that alternative may not be the best choice. Related is a confirmation bias that leads people to reinterpret information that appears to be contrary to their prior beliefs, e.g., about the low likelihood of getting arrested. And, people frequently show a self-serving tendency to attribute their successes to skill and their failures to bad luck (Zuckerman, 1979) , so sellers may view the failures (arrests) as anomalous events.
Why Prices Might Fall When Enforcement Intensity Increases
The paradox that motivated this paper was the observation that drug prices declined when enforcement intensity increased. The forgoing discussion gave some hints as to why increasing enforcement might have perverse effects, but for the most part it argued simply that prices may not be closely related to enforcement risk. That may help explain an absence of a price increase, but it does not in and of itself explain a price decline.
Recall, though, that there are other factors that would have tended to drive prices down (learning by doing, prices initially having been "too high", etc.). If the risks and prices model were accurate, one would have expected these factors to be trumped by the effects of increasing enforcement intensity. If, however, cognitive and perceptual limitations vitiate the price -raising effects of increased enforcement intensity, then these otherwise second-order effects might become dominant.
That is, the argument here is not that a psychologically more plausible model of the response to increased enforcement is that enforcement has a perverse effect on prices.
Rather, the conjecture is that these factors so dilute the impact of enforcement on prices that other factors become more prominent than the "risks and prices" calculations would suggest. This is perhaps best expressed by returning to and modifying the risks and prices equation. Dividing Equation (1) The conjecture raised here is that (1) non-dollar risks may not be fully compensated and (2) where is the attenuation factor describing the extent to which non-dollar risks are not fully compensated and is the "error" term. In the language of this new model, the central conjecture of this paper is that < 1. The observation that most of the issues discussed above explain why increasing enforcement might have a diluted but not perverse effect of prices is consistent with a belief that > 0. Theoretically the actual value could be measured empirically from data series on prices and the various righthand side variables once the error term is understood.
However, at present there is no way to model or quantify the error term because it is an atheoretical residual. The "risks and prices" paradigm offered concrete predictions about and . In a nutshell, that theory was = 0 and = 1. It has been a popular theory not so much because it is universally held to be a good model, but rather because it is almost the only game in town. Unfortunately, if that theory is wrong, there is not another strong competitor standing in the wings.
Conclusion
The "risks and prices" framework gives a clear and plausible argument for why enforcement intensity should be positively related to drug prices. Empirically, however, cocaine and heroin prices have fallen sharply over the last 20 years even though enforcement intensity grew substantially. A variety of factors could help explain this.
Here we explore one that has not received much attention to date.
The risks and prices image of individuals moving into and out of drug selling in a way that balances the expected return from selling and alternative activities makes strong assumptions about human decision making under uncertainty. In particular, it assumes that drug sellers perceive and estimate the relevant probabilities and consequences fairly accurately and that they make choices based on expected payoffs. Research on human decision-making suggests that these conditions are not always or perhaps even often satisfied in practice. To the extent that these cognitive biases and heuristics are prevalent among prospective and active drug sellers, they could help explain why enforcement has not been a more effective deterrent. In particular, if they are sufficiently prevalent, there is no reason why the expected return to drug selling need bear any particular relationship to the expected return from alternative activities. If decisions to sell drugs are not just biased versions of careful calculations but are actually not well thought out at all, then our conclusion holds with even greater force. This is not to say that enforcement is completely unrelated to price. There could still be a stochastic relationship. All other things equal, increased enforcement might still be more likely to drive up price, but the linkage might be so weak that materially different outcomes can be observed. Also, enforcement generates tangible costs for drug sellers, in addition to the deterrence-based mechanism of imposing the risk of non- With a Bernoulli model, the probability of being convicted over a cycle that consists of 37.5 sales is 1 -(1 -0.00009375)^37.5 = 0.0035. The analogous probability of arrest is 0.007.
Likewise, the probability of being convicted over a year that consisted of 60 cycles of 37.5 sales per cycle is 1 -(1 -0.00009375)^2250 = 19%. Recall that the expected time served per conviction was estimated to be 17.44 months. These figures are similar to Reuter et al.'s (1990, p.104) estimate that a year of full time selling caries a 22% probability of incarceration with an average time served of 18 months. 12 The corresponding arrest probability is 34.5%, so the probability of being arrested one or more times but never being convicted is 34.5% -19% = 15.5%. 12 Our Bernoulli model based on national data suggests only a 14% probability of incarceration, but a time served given incarceration of 24 months. So expressing our model in terms of convictions gives a closer match to the Reuter et al. figures than does expressing our model in per-incarceration terms.
We follow Reuter et al. in assuming a cost per year of incarceration of $27,000.
We assume being arrested but not convicted carries a disutility of $2,500. The results are not particularly sensitive to this parameter.
Other Parameters
Reuter et al. (1990) estimate that a year of selling caries a 1.4% risk of death and a 7% risk of serious injury. Assigning dollar values to such outcomes is difficult, but to complete their calculations, they use values of $7,500 per 1% increase in the probability of death and $30,000 per expected serious injury. We use these figures as well.
To convert these into risks per cycle we employ the Bernoulli model. Setting 1 -
(1 -death risk per cycle)^60 = 0.014 suggests that the probability of death per cycle is 0.000235. Likewise the risk of serious injury per cycle is 0.00121.
We assume not dealing pays $10,000 per year and, hence, $166.67 per cycle.
Decision Tree Describing Decision to Deal
We can now draw a decision tree depicting the probabilities and consequences of the possible outcomes of deciding to sell drugs. To keep the tree from getting too complicated, we simply subtract the expected cost due to injuries from all payoffs.
Likewise, although multiple arrests and convictions are possible, we distinguish only between the outcomes of "at least one conviction", "at least one arrest but no conviction", and "no arrest" (in addition to the outcome of "death"). When the outcome is "death" we ignore criminal justice sanctions. When the outcome is either death or conviction, we assume the individual made and benefited from half of the sales they would have executed had they neither been arrested nor killed. We assume being arrested but not convicted has no impact on earnings from drug sales.
Appendix B: Prospect Theory
Detailed presentations of prospect theory are available elsewhere (Kahneman & Tversky, 1979 Tversky & Kahneman, 1992 ). Here we simply present key features of the formal model.
Value Function
Expected utility theory posits a concave utility function defined on total wealth.
Prospect theory posits an asymmetric S-shaped utility function defined in terms of gains and losses relative to a currently salient reference point, often (but not always) the status quo. Specifically, Empirical estimates suggest that = = 0.88, and that = 2.25. This value function suggests that, ceteris paribus, decision makers will be risk averse in the domain of gains and risk seeking in the domain of losses. The parameter represents loss aversion, the empirically well-substantiated finding that decision makers tend to weigh losses over twice as heavily as equivalent gains.
Decision Weighting Function
Expected utility theory weights outcome utilities by the subjective probability of their occurrence. Prospect theory posits a non-linear weighting function, roughly an inverted S-shaped function. A simple one-parameter version (Prelec, 2000) is:
Empirical estimates suggest that = .65, with an inflection point of 1/e. The complete, "cumulative" version of prospect theory (Tversky & Kahneman, 1992 ) no longer applies this weighting function to each outcome separately. Instead, weighting of gains involves "cumulative probabilities" -a focus on the outcome in question or anything better. The weighting of losses involves "decumulative probabilities" -a focus on the outcome in question or anything worse. There is diminishing sensitivity to outcomes in between the largest gain and the largest loss. We describe this process below, but we note that in the situations we analyze here, it did not qualitatively change any of the conclusions suggested by the original prospect theory formulation. The value function and decision weighting function, taken together, imply risk seeking for very low probability gains (p < .05), risk aversion for larger gains, risk aversion for very small probability losses (p < .05), and risk seeking for larger losses.
